Development and validation of a prognostic nomogram for gastrointestinal stromal tumors in the postimatinib era: A study based on the SEER database and a Chinese cohort

BACKGROUND: After the standardization, recording and follow‐up of imatinib use that significantly prolongs survival of gastrointestinal stromal tumors (GISTs), a comprehensive reassessment of the prognosis of GISTs is necessary and more conductive to treatment options. METHODS: A total of 2185 GISTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu, Wang, Yuhao, Luo, Jialin, Wang, Haoyuan, Zhao, Yan, Nie, Yongzhan, Yang, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469741/
https://www.ncbi.nlm.nih.gov/pubmed/37329178
http://dx.doi.org/10.1002/cam4.6240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469741/
https://www.ncbi.nlm.nih.gov/pubmed/37329178
http://dx.doi.org/10.1002/cam4.6240

Ejemplares similares